Stockscreener 앱 받기
7.38
2.11%
-0.19
전일 마감가:
$7.57
열려 있는:
$7.19
하루 거래량:
68,398
Relative Volume:
0.15
시가총액:
$471.59M
수익:
$198.53M
순이익/손실:
$-63.68M
주가수익비율:
-7.2197
EPS:
-1.0222
순현금흐름:
$-41.50M
1주 성능:
-6.20%
1개월 성능:
-6.20%
6개월 성능:
-0.54%
1년 성능:
-44.95%
1일 변동 폭
$7.16
$7.41
1주일 범위
$7.16
$8.05
52주 변동 폭
$3.92
$15.98
트리스 메디컬 컨셉트 Stock (TMCI) Company Profile
명칭
Treace Medical Concepts Inc
전화
(904) 373-5940
주소
100 PALMETTO PARK PLACE, PONTE VEDRA
TMCI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
7.38 | 471.59M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
112.48 | 196.55B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.44 | 141.03B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
365.87 | 138.80B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
81.34 | 104.60B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.34 | 43.28B | 6.60B | 4.16B | 490.10M | 6.93 |
트리스 메디컬 컨셉트 Stock (TMCI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-31 | 개시 | Lake Street | Buy |
| 2024-12-17 | 재개 | JP Morgan | Neutral |
| 2024-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-08 | 다운그레이드 | Truist | Buy → Hold |
| 2023-09-29 | 개시 | UBS | Buy |
| 2023-05-01 | 개시 | Truist | Buy |
| 2023-04-11 | 개시 | Stephens | Equal-Weight |
| 2022-05-12 | 개시 | BTIG Research | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 개시 | JP Morgan | Overweight |
| 2021-05-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 개시 | SVB Leerink | Outperform |
| 2021-05-18 | 개시 | Stifel | Buy |
모두보기
트리스 메디컬 컨셉트 주식(TMCI)의 최신 뉴스
The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors - Business Wire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Position Reduced by Geode Capital Management LLC - Defense World
Barclays PLC Raises Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Insiders Of Treace Medical Concepts Are Up 58% On Their US$7.31m Purchase - Simply Wall St
Franklin Resources Inc. Acquires Shares of 36,487 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Treace Medical CEO to Present at J.P. Morgan Healthcare Conference on Bunion Surgery Innovation - StockTitan
Treace Medical Concepts (NASDAQ:TMCI) Coverage Initiated by Analysts at Lake Street Capital - Defense World
Lake Street Initiates Coverage of Treace Medical Concepts (TMCI) with Buy Recommendation - MSN
This Vertex Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Tuesday - Benzinga
Treace Medical Concepts (NASDAQ:TMCI) Now Covered by Analysts at Lake Street Capital - MarketBeat
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure - The Manila Times
Treace Medical Launches Groundbreaking Minimally Invasive Bunion Surgery System Targeting 450,000 Annual Procedures - StockTitan
Who Holds the Power? Discover the Forces Behind Treace Medical Concepts! - Jomfruland.net
With 54% institutional ownership, Treace Medical Concepts, Inc. (NASDAQ:TMCI) is a favorite amongst the big guns - Yahoo Finance
State Street Corp Raises Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
10,003 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Acquired by HighTower Advisors LLC - Defense World
Stifel Financial Corp Has $776,000 Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $7.88 Average PT from Brokerages - Defense World
Treace Medical Concepts (NASDAQ:TMCI) Stock Price Expected to Rise, Truist Financial Analyst Says - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Fmr LLC Purchases 54,353 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. announced that it expects to receive $2.1 million in funding - Marketscreener.com
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - The Eastern Progress Online
Analysts Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) PT at $7.88 - MarketBeat
Deep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings) - Benzinga
Treace Medical Concepts’ (TMCI) Neutral Rating Reaffirmed at JPMorgan Chase & Co. - Defense World
Truist Financial Forecasts Strong Price Appreciation for Treace Medical Concepts (NASDAQ:TMCI) Stock - MarketBeat
Treace Medical Concepts' (TMCI) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co. - MarketBeat
TMCITreace Medical Concepts, Inc. Latest Stock News & Market Updates - StockTitan
Treace Medical Concepts, Inc. Announces First Surgical Cases Utilizing SpeedPlate MicroQuad Implant - Marketscreener.com
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant - The Manila Times
Treace Medical Successfully Launches Revolutionary MicroQuad™ Bunion Surgery Implant - StockTitan
Reviewing AVITA Medical (NASDAQ:RCEL) and Treace Medical Concepts (NASDAQ:TMCI) - Defense World
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities - The Manila Times
Treace Medical Launches First-Ever AI-Powered Patient-Specific Bunion Surgery System in US - StockTitan
Further Upside For Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Could Introduce Price Risks After 84% Bounce - Simply Wall St
Treace Appoints Guy Guglielmino as Chief Commercial Officer - The Manila Times
Treace Medical Concepts, Inc. Appoints Guy Guglielmino as Chief Commercial Officer - Marketscreener.com
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Target Price at $7.40 - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Treace Announces Participation at Stifel 2024 Healthcare Conference - The Manila Times
Treace Medical CEO to Present at Stifel 2024 Healthcare Conference | TMCI Stock News - StockTitan
Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Treace Medi - GuruFocus.com
Treace Medical Concepts Reports Strong Q3 2024 Growth - TipRanks
트리스 메디컬 컨셉트 (TMCI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.24%
0.50%
자본화:
|
볼륨(24시간):